Allurion (ALUR) launched a new program to provide patients access to compounded weight-loss drugs Monday after months of pitching its own weight-loss solution — an ingestible balloon — as an ...
Allurion (ALUR) launched a new program to provide patients access to compounded weight-loss drugs Monday after months of pitching its own weight-loss solution — an ingestible balloon — as an ...
"Our findings suggest that the Allurion Program can be a game-changer for patients who do not respond to GLP-1 treatments," he added. Sources: 1. Gasoyan H, Pfoh ER, Schulte R, Le P, Butsch WS, ...